Legend Capital Portfolio: Korean Medical AI Company Lunit to List on KOSDAQ in 2Q2022
Retrieved on:
Tuesday, April 26, 2022
According to Korean media reports, Lunit is considered one of the most promising medical AI IPOs in Korea in the first half of 2022.
Founded in 2020, Innostellar Biotherapeutics is a biopharmaceutical startup company focusing on gene therapy for innovative drug discovery, manufacture, and commercialization.
HONG KONG, Apr 7, 2022 - (ACN Newswire) - On 31 March 2022, Legend Capital's portfolio company Jiangsu Recbio Technology Co., Ltd. ("Recbio", stock code: 2179.HK), a leading novel vaccines company, went public on the Hong Kong Stock Exchange.